[
  {
    "ts": "2026-02-14T02:08:53+00:00",
    "headline": "Boston Scientific (BSX) Valuation After Mixed Q4 2025 Results And 2026 Growth Outlook",
    "summary": "Boston Scientific (BSX) is in focus after reporting Q4 2025 and full year results that combined higher sales and earnings with mixed signals in key growth areas and guidance for 2026. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 20.28% and a 90 day return of 27.23%. However, the 3 year total shareholder return of 60.57% and 5 year total shareholder return of 96.50% remain well above these short term...",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-valuation-mixed-020853013.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "10746e69-237b-3873-9df7-d9b5f7e4c1f9",
      "content": {
        "id": "10746e69-237b-3873-9df7-d9b5f7e4c1f9",
        "contentType": "STORY",
        "title": "Boston Scientific (BSX) Valuation After Mixed Q4 2025 Results And 2026 Growth Outlook",
        "description": "",
        "summary": "Boston Scientific (BSX) is in focus after reporting Q4 2025 and full year results that combined higher sales and earnings with mixed signals in key growth areas and guidance for 2026. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 20.28% and a 90 day return of 27.23%. However, the 3 year total shareholder return of 60.57% and 5 year total shareholder return of 96.50% remain well above these short term...",
        "pubDate": "2026-02-14T02:08:53Z",
        "displayTime": "2026-02-14T02:08:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-valuation-mixed-020853013.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-valuation-mixed-020853013.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-14T20:06:58+00:00",
    "headline": "Reassessing Boston Scientific (BSX) After A 30% Pullback In The Share Price",
    "summary": "If you are wondering whether Boston Scientific is attractively priced or looking stretched at around US$74.73 per share, you are not alone. Many investors are reassessing what they are really paying for here. The stock recently closed at US$74.73, with returns of a 2.0% decline over 7 days, 20.3% decline over 30 days, 21.1% decline year to date, and 29.6% decline over 1 year, set against gains of 60.6% over 3 years and 96.5% over 5 years. Recent news has focused on Boston Scientific's...",
    "url": "https://finance.yahoo.com/news/reassessing-boston-scientific-bsx-30-200658822.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "83519af4-98ee-3c26-9338-821b2b48523f",
      "content": {
        "id": "83519af4-98ee-3c26-9338-821b2b48523f",
        "contentType": "STORY",
        "title": "Reassessing Boston Scientific (BSX) After A 30% Pullback In The Share Price",
        "description": "",
        "summary": "If you are wondering whether Boston Scientific is attractively priced or looking stretched at around US$74.73 per share, you are not alone. Many investors are reassessing what they are really paying for here. The stock recently closed at US$74.73, with returns of a 2.0% decline over 7 days, 20.3% decline over 30 days, 21.1% decline year to date, and 29.6% decline over 1 year, set against gains of 60.6% over 3 years and 96.5% over 5 years. Recent news has focused on Boston Scientific's...",
        "pubDate": "2026-02-14T20:06:58Z",
        "displayTime": "2026-02-14T20:06:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reassessing-boston-scientific-bsx-30-200658822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reassessing-boston-scientific-bsx-30-200658822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-14T22:08:16+00:00",
    "headline": "Boston Scientific Stock Slide Tests Support As Outlook And Value Diverge",
    "summary": "Boston Scientific (NYSE: BSX) shares have fallen sharply in recent weeks, taking the stock back to technical support levels not seen for over a year. The pullback has coincided with reported institutional selling, even as the company reports solid operating performance. Management has expressed confidence in continuing to grow faster than the broader market, highlighting a gap between investor sentiment and the company outlook. For you as an investor, the tension between price action and...",
    "url": "https://finance.yahoo.com/news/boston-scientific-stock-slide-tests-220816380.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "58be92ae-6ab6-3e2e-8e0b-17de7a4aac1f",
      "content": {
        "id": "58be92ae-6ab6-3e2e-8e0b-17de7a4aac1f",
        "contentType": "STORY",
        "title": "Boston Scientific Stock Slide Tests Support As Outlook And Value Diverge",
        "description": "",
        "summary": "Boston Scientific (NYSE: BSX) shares have fallen sharply in recent weeks, taking the stock back to technical support levels not seen for over a year. The pullback has coincided with reported institutional selling, even as the company reports solid operating performance. Management has expressed confidence in continuing to grow faster than the broader market, highlighting a gap between investor sentiment and the company outlook. For you as an investor, the tension between price action and...",
        "pubDate": "2026-02-14T22:08:16Z",
        "displayTime": "2026-02-14T22:08:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-stock-slide-tests-220816380.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-stock-slide-tests-220816380.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]